Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital

SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma

Research output: Contribution to journalReviewpeer-review

  1. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antibiotics during childhood and development of appendicitis-a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Danish severe asthma register: an electronic platform for severe asthma management and research

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Real-world evidence is important to help unravel unanswered problems in severe asthma and is valuable to better understand the patient experience and common clinical practice. The Severe Heterogeneous Asthma Registry, Patient-centred (SHARP) Clinical Research Collaboration is created as a network of national registries and severe asthma centres that work together to perform registry based real-world research and clinical studies on a pan-European scale. Such collaboration requires a new, innovative design to overcome the many issues that arise with large-scale data collection across national borders. SHARP has developed a platform that offers a federated analysis approach where national registry data are transformed and integrated into a common data model (CDM). The CDM then allows a local analysis of de-identified patient data and subsequent aggregate (meta-)analysis. To facilitate an easily accessible way to set up new registries, SHARP enables new registries to take part in a central database, based on already proven technology. Next to being economical, this linkage ensures data from different SHARP central members to be comparable. Technological advancements lead to an ever-expanding rate of patient data that will be collected; with the collective effort of the pan-European severe asthma research community SHARP hopes to ensure that they are well equipped to enter a new era of medical research, with the ultimate goal to positively impact the lives of patients with severe asthma.

Original languageEnglish
JournalERJ Open Research
Issue number2
Publication statusPublished - Apr 2021

ID: 65948198